Intrinsic Value of S&P & Nasdaq Contact Us

The Pennant Group, Inc. PNTG NASDAQ

NASDAQ Global Select • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
65/100
3/7 Pass
SharesGrow Intrinsic Value
$35.68
+16.4%
Analyst Price Target
$39.00
+27.2%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

The Pennant Group, Inc. (PNTG) trades at a trailing P/E of 36.6, forward P/E of 23.1. Trailing earnings yield is 2.73%, forward earnings yield 4.32%. PEG 1.83. Graham Number is $14.40.

Criteria proven by this page:

  • VALUE (48/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
  • Forward P/E 23.1 (down from trailing 36.6) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 1.83 — between 1.0–2.0 indicates moderate valuation relative to growth.
  • Trailing Earnings Yield 2.73% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 4.32% as earnings recover.
  • Analyst consensus target $39.00 (+27.2% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 65/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
65/100
SG Score
View full scorecard →
~
VALUE
48/100
Price-to-Earnings & upside
Proven by this page
FUTURE
88/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
38/100
→ Income
GROWTH
100/100
→ Income
INCOME
30/100
→ Income

Valuation Snapshot — PNTG

Valuation Multiples
P/E (TTM)36.6
Forward P/E23.1
PEG Ratio1.83
Forward PEG0.40
P/B Ratio3.26
P/S Ratio1.14
EV/EBITDA25.0
Per Share Data
EPS (TTM)$0.85
Forward EPS (Est.)$1.33
Book Value / Share$10.80
Revenue / Share$27.35
FCF / Share$0.95
Yields & Fair Value
Earnings Yield2.73%
Forward Earnings Yield4.32%
Dividend Yield0.00%
Graham Number$14.40
SharesGrow IV$35.68 (+16.4%)
Analyst Target$39.00 (+27.2%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 53.5 0.00 0.00 1.95 -
2017 42.6 1.70 7.64 1.67 -
2018 26.8 0.45 7.52 1.47 -
2019 361.6 -4.32 12.95 2.72 1.26%
2020 103.4 0.20 16.85 4.16 -
2021 243.2 -2.81 5.95 1.49 -
2022 48.0 0.24 2.64 0.67 -
2023 31.1 0.32 2.96 0.76 -
2024 36.7 0.61 2.82 1.19 -
2025 32.9 1.69 2.93 1.03 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $0.28 $217.23M $7.89M 3.6%
2017 $0.35 $250.99M $9.87M 3.9%
2018 $0.56 $286.06M $15.68M 5.5%
2019 $0.09 $338.53M $2.55M 0.8%
2020 $0.52 $390.95M $15.74M 4%
2021 $0.07 $439.69M $2.15M 0.5%
2022 $0.22 $473.24M $6.64M 1.4%
2023 $0.44 $544.89M $13.38M 2.5%
2024 $0.70 $695.24M $22.56M 3.2%
2025 $0.84 $947.71M $29.58M 3.1%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $1.31 $1.25 – $1.35 $1.16B $1.15B – $1.18B 4
2027 $1.57 $1.53 – $1.58 $1.25B $1.22B – $1.28B 4
2028 $1.92 $1.91 – $1.92 $1.29B $1.27B – $1.31B 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message